|
2026
|
Invention
|
Technologies for determining tumor sample purity and/orgenomic characteristics using single nucle... |
|
|
Invention
|
Technologies for determining tumor sample purity and/or genomic characteristics. Presented herein... |
|
|
Invention
|
Technologies for mutation detection using tumor modeling and feedback. Presented herein are metho... |
|
|
Invention
|
Technologies for neoantigen prioritization based on tumor modeling and clonality states. Presente... |
|
|
Invention
|
Combination therapy comprising an rna cancer vaccine and a multispecific binding agent targeting ... |
|
|
Invention
|
Coronavirus and influenza immunogenic combinations. This disclosure relates to the field of RNA t... |
|
2025
|
Invention
|
Measuring nucleic acid integrity. The present invention relates to a method of measuring nucleic ... |
|
|
Invention
|
Measuring nucleic acid integrity. The present invention relates to a method of measuring RNA inte... |
|
|
Invention
|
Anti-ctla4 antibodies for treating non-small cell lung cancer. The present invention relates to a... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer |
|
|
Invention
|
Combination comprising a tumor necrosis factor receptor 2 agonist. The present invention relates ... |
|
|
Invention
|
Agents and methods for targeted delivery of immune effector cells. Provided are methods and agent... |
|
|
Invention
|
Methods and systems for mass-spectrometry-based detection of non-canonical peptides. Presented he... |
|
|
Invention
|
Rna for preventing or treating tuberculosis. The present disclosure provides agents and methods f... |
|
|
Invention
|
Cartridge for a pharmaceutical process. The present disclosure is directed to a cartridge for sto... |
|
|
Invention
|
Engineered ch1 and cl domains for the prevention of chain mispairing. The present invention is co... |
|
|
P/S
|
Chemical agents for laboratory use, in particular nucleic acids, peptides and proteins; chemical ... |
|
|
Invention
|
Compositions and methods. A method of producing a composition containing a nucleic acid-lipid par... |
|
|
Invention
|
Tnfr1 antagonists and tnfr2 agonists for treating acute pain. The present invention relates to mo... |
|
|
Invention
|
Combination therapy comprising anti-ctla4 antibodies and anti-pd-1 antibodies for platinum-resist... |
|
|
Invention
|
Peptidoglycan hydrolases having a chap domain with engineered active site. The present invention ... |
|
|
Invention
|
Peptidoglycan hydrolases having multiple enzymatically active domains. The present invention is g... |
|
|
Invention
|
Hpv-16 t cell receptor uses and compositions thereof. The present disclosure provides T cell rece... |
|
|
Invention
|
Tumor antigens for determining cancer therapy.
The present invention relates to the treatment of... |
|
|
Invention
|
Minimal polypeptide-encoding rnas. The present invention relates to minimal polypeptide-encoding ... |
|
|
Invention
|
T-cell receptors (tcrs). The present disclosure provides methods for identifying T-cell receptors... |
|
|
Invention
|
Potency assay for multiple coding nucleic acids. The invention provides potency assays for simult... |
|
|
Invention
|
Sars-cov-2 immunogenic compositions. Disclosed herein are compositions comprising protein antigen... |
|
|
Invention
|
Agonistic tnf receptor binding agents.
The present invention relates to binding agents binding t... |
|
|
Invention
|
Humanized single-domain antibodies binding to epitope tags.
The present invention provides human... |
|
|
Invention
|
Methods for providing single-stranded rna.
The present invention relates to methods for providin... |
|
|
Invention
|
Chimeric proteins comprising non-human protein domains for enhancing antigenicity. The disclosure... |
|
|
Invention
|
Combination therapy comprising anti-ctla4 antibodies and chemotherapy for cancer treatment. 1 BNT... |
|
|
Invention
|
Process for preparing oligosaccharide complexes. The present disclosure provides methods and syst... |
|
|
Invention
|
Agents and methods for targeted delivery to cells. The invention relates to agents and methods fo... |
|
|
Invention
|
Compositions and methods. A method of producing a nucleic acid-lipid particle, the method compris... |
|
|
Invention
|
Binding agents binding to epcam and cd137.
The present invention provides a binding agent that b... |
|
|
Invention
|
Methods and compositions for designing epitope strings with linkers. The present disclosure provi... |
|
|
Invention
|
Vaccine composition for eliciting an ebv-specific cd8+ t cell response. The present invention rel... |
|
|
Invention
|
Hsv antigen fragments and related methods. The present disclosure provides compositions for deliv... |
|
|
Invention
|
Nucleic acid particle. The present invention generally relates to nucleic acid particles, in part... |
|
2024
|
P/S
|
Pharmaceutical preparations; vaccines. |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
P/S
|
Downloadable computer software used for biotechnology research and development; downloadable comp... |
|
|
P/S
|
Database management; data management; data processing; data management services; compilation of d... |
|
|
P/S
|
Computer software; computer software comprising algorithms for the selection of pharmaceutical re... |
|
|
P/S
|
Databases; database engines; data processing software; data management software; data mining soft... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
P/S
|
Pharmaceuticals; vaccines. |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer |
|
2023
|
Invention
|
Rna compositions targeting hiv.
The present disclosure provides compositions (e.g., pharmaceutic... |
|
|
Invention
|
Composition.
A composition comprising: (a) an active ingredient; and (b) a lipid mixture compris... |
|
|
Invention
|
Rna capping efficiency assay.
A method of quantifying RNA capping efficiency, the method compris... |
|
|
P/S
|
Chemical products for medical and veterinary purposes;
medical and pharmaceutical preparations. ... |
|
|
P/S
|
Chemical preparations for medical and veterinary purposes, namely, for neuroregeneration and the ... |
|
|
Invention
|
Combination vaccines against coronavirus infection, influenza infection, and/or rsv infection.
T... |
|
|
Invention
|
Rna constructs and uses thereof.
Disclosed herein are RNA polynucleotides comprising a 5′ Cap, a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and... |
|
|
Invention
|
Nucleic acid complexes and uses thereof.
The present disclosure provides complexes and methods o... |
|
|
Invention
|
Compositions for delivery of plasmodium csp antigens and related methods.
The present disclosure... |
|
|
Invention
|
Rna for preventing or treating tuberculosis.
The disclosure provides agents and methods for prev... |
|
|
Invention
|
Rna lipid nanoparticles (lnps) comprising a polyoxazoline and/or polyoxazine polymer.
The presen... |
|
|
P/S
|
Pharmaceutical products for treatment of cancer |
|
2022
|
P/S
|
Personal development by means of training and further training for doctors and scientists in the ... |
|
|
Invention
|
Coronavirus vaccines and methods of use.
Compositions and methods for the prevention and/or trea... |
|
|
P/S
|
Transportable buildings of metal, namely, modular containers; transportable buildings of metal, n... |
|
|
P/S
|
Transportable buildings of metal; transportable buildings of metal for the manufacture and fillin... |
|
|
P/S
|
Transportable buildings of metal; transportable buildings of
metal for the manufacture and filli... |
